Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Pharvaris N.V. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 51 | +16 |
| Shares | 43.0M | 2.27K | 45.0M | +2.04M (+4.7%) |
| Value | $808.6M | $42.6K | $834.2M | +$25.7M (+3.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Pharvaris N.V. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Octagon Capital Advisors LP | 620,470 | $11.5M | 1.84% |
| Patient Square Capital LP | 242,341 | $4.49M | 1.67% |
| BlackRock, Inc. | 195,348 | $3.62M | 0.00% |
| State Street Corp | 53,980 | $999.7K | 0.00% |
| UBS Asset Management Americas Inc | 48,896 | $905.6K | 0.00% |
| Alps Advisors Inc | 42,308 | $783.5K | 0.01% |
| Jane Street Group, LLC | 28,418 | $526.3K | 0.00% |
| Swiss National Bank | 26,257 | $486.3K | 0.00% |
| Deutsche Bank AG | 16,081 | $297.8K | 0.00% |
| Crestline Management, LP | 15,819 | $293.0K | 0.02% |
| Northern Trust Corp | 15,744 | $291.6K | 0.00% |
| California State Teachers Retirement System | 12,950 | $239.8K | 0.00% |
| Vanguard Group Inc | 12,740 | $235.9K | 0.00% |
| Ghisallo Capital Management LLC | 11,249 | $208.3K | 0.01% |
| Legal & General Group Plc | 8,861 | $164.1K | 0.00% |
| Barclays PLC | 5,700 | $105.6K | 0.00% |
| Public Employees Retirement System of Ohio | 3,100 | $57.4K | 0.00% |
| JPMorgan Chase & Co | 253 | $4.69K | 0.00% |
| Amundi | 84 | $1.50K | 0.00% |
Sold out (3)
Institutions that held Pharvaris N.V. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Walleye Capital LLC | 48,768 | $916.8K |
| Y-Intercept (Hong Kong) Ltd | 15,883 | $298.6K |
| Citadel Advisors LLC | 14,472 | $272.1K |
Not filed for Q3 2024 yet (1)
Institutions that held Pharvaris N.V. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 2,268 | $42.6K |